Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.
Press releases published on July 15, 2025
Award-Winning Holixer from Natural Remedies Delivers Clinically Proven Sleep Support
GlobeNewswire
·
July 15, 2025
BANGALORE, India, July 15, 2025 (GLOBE NEWSWIRE) -- With rising nighttime temperatures disrupting sleep across the United States, clinical research shows Holixer™, a patented and clinically validated extract from Natural Remedies, derived from holy basil ( …
Evestia Clinical to merge with Atlantic Research Group
GlobeNewswire
·
July 15, 2025
Kester Capital-backed Evestia Clinical merges with US-based Atlantic Research Group (ARG) to create a leading independent global specialist CRO in fast-growing markets The merger delivers on Evestia Clinical’s strategy of targeted growth through the …
Myriad Genetics Earns 2025 Great Place To Work Certification™
GlobeNewswire
·
July 15, 2025
SALT LAKE CITY, July 15, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced it has received the Great Place to Work Certification for the third year in a row. The …
Beverly Hills MD Launches Metabolic Reset: A Revolutionary Weight Management Support Formula
GlobeNewswire
·
July 15, 2025
BEVERLY HILLS, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Beverly Hills MD®, founded by renowned cosmetic surgeons Dr. John Layke and Dr. Payman Danielpour, is proud to announce the launch of Beverly Hills MD Metabolic Reset, a cutting-edge supplement …
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
GlobeNewswire
·
July 15, 2025
SAN JOSE, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has …
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
GlobeNewswire
·
July 15, 2025
$10 million securities purchase agreement provides efficient and flexible funding in support of strategic multi-million dollar growth initiatives Discussions underway to expand adoption of ChemoFx in the U.S. and accelerate initial launch in Europe …
Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation
GlobeNewswire
·
July 15, 2025
CANTON, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices
GlobeNewswire
·
July 15, 2025
VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has directed …
SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System
GlobeNewswire
·
July 15, 2025
FORT LAUDERDALE, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and …
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
GlobeNewswire
·
July 15, 2025
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition of the SmarTest® …
Sienna Announces July Dividend
GlobeNewswire
·
July 15, 2025
MARKHAM, Ontario, July 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of July 2025, representing $0. …
MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy
GlobeNewswire
·
July 15, 2025
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies, today announced the publication of a peer-reviewed …
IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan
GlobeNewswire
·
July 15, 2025
Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated …
Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled
GlobeNewswire
·
July 15, 2025
Vancouver, Canada, July 15, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
GlobeNewswire
·
July 15, 2025
BERKELEY, Calif. and MAINZ, Germany, July 15, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major …
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
GlobeNewswire
·
July 15, 2025
TARPON SPRINGS, Fla., July 15, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway …
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
GlobeNewswire
·
July 15, 2025
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the …
Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide
GlobeNewswire
·
July 15, 2025
Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension This patent covers novel cyclic peptides and their use in treating solid tumors BASKING RIDGE, N.J, July 15, 2025 (GLOBE NEWSWIRE) -- …
OncoC4 to Present at the 2025 Orphan Drug Summit on Strategies to Eliminate Anti-Drug Antibodies in Orphan Therapies
GlobeNewswire
·
July 15, 2025
ROCKVILLE, Md., July 15, 2025 (GLOBE NEWSWIRE) -- OncoC4, Inc., a late-stage biopharmaceutical company developing novel medicines for cancer, today announced it will present at the upcoming 2025 Orphan Drug Summit being held July 16-27, 2025, in Boston, …
Florida Oncology and Hematology Expands Fort Myers Clinic, Adds PET Services
GlobeNewswire
·
July 15, 2025
FORT MYERS, Fla., July 15, 2025 (GLOBE NEWSWIRE) -- Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has expanded its Fort Myers clinic at 14551 Hope Center Loop to include radiology services. Current and prospective …